Fredun Pharmaceuticals Annual Report

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Fredun Pharmaceuticals Q2 FY27 Results: Net Profit ₹18.6 Cr, Up 97.9% YoY

Fredun Pharmaceuticals Ltd reported revenue from operations of ₹265.9 Cr (+85.2% YoY) and net profit of ₹18.6 Cr (+97.9% YoY) for Q2 FY27.

Key figure

Net profit ₹18.6 Cr · +97.9% YoY

Board Meeting Date

Fredun Pharmaceuticals Board Meeting Date

Fredun Pharmaceuticals will hold a board meeting on 05 November 2026 to consider half-year results. Trading window stays closed until 48 hours after results.

Convertible WarrantsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Fredun Pharmaceuticals Convertible Warrants

Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.

Other Announcement

Fredun Pharmaceuticals Other Announcement

Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.

Other Announcement

Fredun Pharmaceuticals Other Announcement

Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.

Business Update

Fredun Pharmaceuticals Business Update

Fredun Pharma announces strategic pet-care acquisitions, capacity expansion, and a 100% branded portfolio target by 2029. H1 FY27 business update outlines multi-pillar growth transformation.

manufacturing infrastructure (Palghar plant)

90000 sq. ft.

Annual ReportMrugesh Trading Ltd MRUTR

Mrugesh Trading Annual Report

Mrugesh Trading submitted its FY2025-26 Annual Report for the 42nd AGM to be held on 30 September 2026. The filing contains the full annual report, including financials and governance disclosures.

Annual ReportGeneric Engineering Construction and Projects Ltd GENCON

Generic Engineering Construction and Projects Annual Report

Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.

Annual ReportVineet Laboratories Ltd VINEETLAB

Vineet Laboratories Annual Report

Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.

Annual ReportIndrayani Biotech Ltd INDRANIB

Indrayani Biotech Annual Report

Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.

Annual ReportESDS Software Solution Ltd ESDS

ESDS Software Solution Annual Report

ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.

Annual ReportThe Orissa Minerals Development Company Ltd ORISSAMINE

The Orissa Minerals Development Company Annual Report

Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.